Is Acorda Therapeutics Inc (NASDAQ: ACOR) Doomed From The Get-Go?

The trading price of Acorda Therapeutics Inc (NASDAQ:ACOR) floating lower at last check on Tuesday, April 02, closing at $2.30, -82.93% lower than its previous close.

In examining the 52-week price action we see that the stock hit a 52-week high of $24.20 and a 52-week low of $8.98. Over the past month, the stock has lost -83.80% in value.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Acorda Therapeutics Inc, whose market valuation is $2.85 million at the time of this writing, is expected to release its quarterly earnings report May 02, 2024 – May 06, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $0 per share this quarter, however they have predicted annual earnings per share of $0 for 2024 and $0 for 2025.

From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $138.92 million.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Acorda Therapeutics Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ACOR has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Sell.

A quick review shows that ACOR’s price is currently -81.93% off the SMA20 and -83.91% off the SMA50. The RSI metric on the 14-day chart is currently showing 19.03, and weekly volatility stands at 4.58%. When measured over the past 30 days, the indicator reaches 6.09%. Acorda Therapeutics Inc (NASDAQ:ACOR)’s beta value is currently sitting at 1.46, while the Average True Range indicator is currently displaying 1.58.

To see how Acorda Therapeutics Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: ACOR stock’s performance was -82.93% at last check in today’s session, and -79.90% in the past year.

An evaluation of the daily trading volume of Acorda Therapeutics Inc (NASDAQ:ACOR) indicates that the 3-month average is 4.03K. However, this figure has increased over the past 10 days to an average of 4520.0.

Currently, records show that 1.24 million of the company’s shares remain outstanding. The insiders hold 0.69% of outstanding shares, whereas institutions hold 12.69%. The stats also highlight that short interest as of Mar 15, 2024, stood at 9460.0 shares, resulting in a short ratio of 2.21 at that time. From this, we can conclude that short interest is 0.76% of the company’s total outstanding shares. It is noteworthy that short shares in March were down slightly from the previous month’s figure, which was 10250.0. However, since the stock’s price has seen -84.76% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.